IPP Bureau
CK Birla Hospital signs MoU Intuitive for robotic-assisted surgery
By IPP Bureau - August 30, 2023
Hospital joins with Intuitive to install da Vinci systems to support enhanced healthcare delivery and patient outcomes across India
BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint
By IPP Bureau - August 29, 2023
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation
By IPP Bureau - August 29, 2023
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Thermo Fisher Scientific launches ‘Made in India’ TSV Series lab refrigerators and freezers
By IPP Bureau - August 29, 2023
The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions
Apollo’s Apollo Connect program bets big on expanding access and elevating care
By IPP Bureau - August 29, 2023
Aims to build the largest connected healthcare ecosystem in India
Global Hospitals Parel Mumbai completes 100 successful robotic surgeries
By IPP Bureau - August 29, 2023
The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology
Briefs: Granules India
By IPP Bureau - August 28, 2023
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Lupin receives approval from USFDA for Pirfenidone Tablets
By IPP Bureau - August 28, 2023
This product will be manufactured at Lupin's Pithampur facility in India
Zydus to present on ZYIL1 at the International Congress of Parkinson's Disease and Movement Disorders
By IPP Bureau - August 28, 2023
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
IBL Healthcare invests in KNISS Laboratories
By IPP Bureau - August 28, 2023
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Gland Pharma receives 2 observations under 483 for Pashamylaram facility
By IPP Bureau - August 28, 2023
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
Zydus receives final approval from the USFDA for zinc sulfate injection pharmacy bulk package vials
By IPP Bureau - August 25, 2023
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
Lynparza plus abi/pred approved in Japan for treatment of prostate cancer
By IPP Bureau - August 25, 2023
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
Roche provides update on Phase III Skyscraper-01 study in PD-L1-high metastatic non-small cell lung cancer
By IPP Bureau - August 25, 2023
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators
Intuitive and Max Healthcare to launch TPO Centre for robotic-assisted surgery
By IPP Bureau - August 25, 2023
Centre aims to train surgeons and other healthcare professionals from India and Southeast Asia in robotic-assisted surgery
